Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)

SHE:002898 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	6.88	48.84	87.12	72.27	113.31	58.08
Trading Asset Securities	-	-	2.14	-	-	-
Cash & Short-Term Investments	6.88	48.84	89.26	72.27	113.31	58.08
Cash Growth	-78.72%	-45.28%	23.51%	-36.22%	95.10%	-39.67%
Accounts Receivable	103.98	99.68	55.27	88.85	84.98	80.87
Other Receivables	8.03	4.03	14.71	19.68	33.83	8.51
Receivables	112.02	103.7	69.98	108.53	118.81	89.38
Inventory	88.48	94.08	88.87	63.97	52.98	62.74
Prepaid Expenses	-	-	-	-	-	0.01
Other Current Assets	3.82	3.21	8.19	9.59	4.05	32.69
Total Current Assets	211.19	249.83	256.3	254.36	289.14	242.89
Property, Plant & Equipment	390.77	402.23	352.11	394.25	405.59	408.8
Long-Term Investments	4.9	4.9	69.86	62.28	45.19	38.66
Other Intangible Assets	69.39	67.71	67	67.77	70.46	74.65
Long-Term Deferred Tax Assets	1.64	3.71	1.96	13.58	18.57	21.57
Long-Term Deferred Charges	60.37	59.16	45.74	36.7	33.23	23.5
Other Long-Term Assets	18.93	20.68	20.88	19.08	20.61	3.89
Total Assets	757.19	808.22	813.84	848.01	882.78	813.96
Accounts Payable	60.82	62.31	63.53	94.47	94.15	64.71
Accrued Expenses	10.43	21.03	17.55	22.39	14.55	10.84
Short-Term Debt	123.27	128.13	90.05	100.06	100.12	90
Current Portion of Long-Term Debt	23.99	6.27	11.9	29.63	28.86	1.79
Current Portion of Leases	0.42	0.5	0.36	0.24	0.89	-
Current Income Taxes Payable	0.07	-	0.02	0.75	0.74	0.17
Current Unearned Revenue	12.5	11.51	11.53	23.53	8.24	8.88
Other Current Liabilities	11.9	25.27	32.08	25.38	19.03	13.87
Total Current Liabilities	243.4	255.02	227.01	296.45	266.58	190.24
Long-Term Debt	8.5	29.86	25.08	13.32	42.91	28.26
Long-Term Leases	0.18	0.33	0.04	0.18	0.27	-
Long-Term Unearned Revenue	2.74	2.6	2.84	3.08	3.33	3.42
Long-Term Deferred Tax Liabilities	9.46	9.62	9.76	8.63	6.04	5.03
Other Long-Term Liabilities	7.45	11.51	13.23	-	-	-
Total Liabilities	271.73	308.95	277.96	321.67	319.12	226.96
Common Stock	176	176	176	176	176	176
Additional Paid-In Capital	288.47	288.47	288.47	288.47	288.47	288.47
Retained Earnings	19.91	34.75	71.41	61.88	99.19	122.53
Comprehensive Income & Other	1.07	0.06	-	-	-	-
Shareholders' Equity	485.45	499.28	535.88	526.35	563.66	587
Total Liabilities & Equity	757.19	808.22	813.84	848.01	882.78	813.96
Total Debt	156.36	165.09	127.42	143.43	173.05	120.05
Net Cash (Debt)	-149.48	-116.25	-38.16	-71.16	-59.74	-61.97
Net Cash Per Share	-0.85	-0.66	-0.22	-0.40	-0.34	-0.35
Filing Date Shares Outstanding	176	176	176	176	176	176
Total Common Shares Outstanding	176	176	176	176	176	176
Working Capital	-32.21	-5.19	29.29	-42.09	22.57	52.65
Book Value Per Share	2.76	2.84	3.04	2.99	3.20	3.34
Tangible Book Value	416.07	431.56	468.89	458.58	493.21	512.35
Tangible Book Value Per Share	2.36	2.45	2.66	2.61	2.80	2.91
Buildings	300.56	301.56	311.75	335.26	323.12	278.98
Machinery	228.95	226.12	213.31	207.43	194.92	161.46
Construction In Progress	6.28	5.89	1.44	1.38	9.21	65.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.